US Broker Ratings

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential with a 12.58% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the global pharmaceutical arena, offers a compelling narrative for investors with its diversified portfolio and strategic international presence. Headquartered in..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unveiling a 19.59% Potential Upside in the Medical Device Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a stalwart in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $11.51 billion, this UK-based company..

Medtronic plc (MDT): Investor Outlook with a 15% Upside Potential

Medtronic plc (NYSE: MDT) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Galway, Ireland, Medtronic has established itself as..

Waters Corporation (WAT) Stock Analysis: Navigating Its 113.40% Revenue Growth Amidst a Promising Analyst Consensus

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, specifically in the diagnostics and research industry. Headquartered in Milford, Massachusetts, Waters Corporation has carved out a..

GSK plc (GSK) Stock Analysis: Exploring a 21.71% Potential Upside for Investors

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, is attracting attention from investors with its promising potential upside of 21.71%. Operating in the drug manufacturing industry, GSK is..

BioNTech SE (BNTX) Stock Analysis: Navigating a 22.28% Potential Upside Amid Biotechnology Volatility

BioNTech SE (BNTX), a German biotechnology heavyweight, has been a notable player in the healthcare sector, primarily recognized for its groundbreaking work in immunotherapies. With a market capitalization of $24.3..

Mettler-Toledo International (MTD) Stock Analysis: Evaluating a 12.29% Potential Upside in the Diagnostics Sector

Mettler-Toledo International Inc. (NYSE: MTD), a leading player in the diagnostics and research industry, has long been a name synonymous with precision. Headquartered in Greifensee, Switzerland, this healthcare sector giant..

STERIS plc (STE) Stock Analysis: 24.85% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, STERIS plc (NYSE: STE) presents a compelling case with a potential upside of 24.85%. This Ohio-headquartered company specializes in infection prevention products..

Centene Corporation (CNC) Stock Analysis: Evaluating the 8% Upside Potential Amidst Healthcare Growth

Centene Corporation (NYSE: CNC), a significant player in the healthcare plans industry, presents an intriguing opportunity for investors as it navigates the complexities of the U.S. healthcare landscape. With a..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A 49% Potential Upside Amidst Biotech Innovations

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands at the forefront of biotechnology innovation, leveraging its expertise in ribonucleic acid interference (RNAi) to develop groundbreaking therapeutics. With a robust market capitalization of..

Natera, Inc. (NTRA) Stock Analysis: A $47 Billion Market Cap Powerhouse with a Robust Growth Trajectory

Natera, Inc. (NTRA), a leading player in the diagnostics and research sector, has been making waves in the healthcare industry with its innovative molecular testing services. Based in Austin, Texas,..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Potential 2.39% Upside Amidst Market Volatility

Molina Healthcare Inc (NYSE: MOH) stands as a prominent player in the healthcare plans industry, with a focus on providing managed healthcare services to low-income families and individuals across the..

Veeva Systems Inc. (VEEV) Stock Report: Exploring a 13.3% Upside Potential in the Healthcare Sector

Veeva Systems Inc. (NYSE: VEEV) has carved a niche for itself in the healthcare sector, specifically in providing cloud-based solutions tailored for the life sciences industry. With a market capitalization..

Bristol-Myers Squibb (BMY) Stock Analysis: Exploring Growth Potential in the Biopharma Sector

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the healthcare sector, continues to captivate investors with its robust portfolio and strategic initiatives aimed at driving growth. With a market capitalization..

The Cigna Group (CI) Stock Analysis: Evaluating a 20.87% Potential Upside for Healthcare Investors

Investors eyeing The Cigna Group (CI) will find the healthcare giant’s market position and financial metrics compelling, particularly given the stock’s potential upside of 20.87% as suggested by recent analyst..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating Growth with a 5.75% Potential Upside

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player in the healthcare sector, with a significant footprint in the medical care facilities industry across the United States. With a..

CVS Health Corporation (CVS) Stock Analysis: Exploring a 22.84% Potential Upside with Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a dominant player in the healthcare sector, has been capturing the attention of investors with its robust market presence and promising financial outlook. With a..

Sanofi (SNY) Stock Analysis: Exploring a Potential 25.61% Upside and Robust Dividend Yield

Sanofi (SNY), the Paris-based healthcare giant, stands out in the drug manufacturing sector with its impressive market capitalization of $102.48 billion. Known for its innovative approach in developing therapeutic solutions..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a 19% Upside Potential

Agilent Technologies, Inc. (NYSE: A) stands as a formidable presence in the healthcare sector, specifically within the diagnostics and research industry. With a robust market capitalization of $41.43 billion, this..

Stryker Corporation (SYK) Stock Analysis: Unlocking a 36.55% Potential Upside in the Medical Device Sector

Stryker Corporation (NYSE: SYK), a prominent player in the healthcare sector, is capturing investor attention with its robust market position and promising growth potential. As a leader in medical devices,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds